feed,title,long_url,short_url
InsiderMonkey,Delayed AI Software Rollout and Tariff Related Uncertainty Put Pressure on Apple (AAPL),https://insidermonkey.com/blog/--1581620,
InsiderMonkey,Aristotle Atlantic Large Cap Growth Strategy’s Q2 2025 Investor Letter,https://insidermonkey.com/blog/--1581595,
InsiderMonkey,Varied Growth Signals Lifted Interactive Brokers Group (IBKR) in Q2,https://insidermonkey.com/blog/--1581500,
InsiderMonkey,Choice Hotels International (CHH) Declined 4.49% in Q2 Due to Investors’ Concerns,https://insidermonkey.com/blog/--1581487,
InsiderMonkey,10 Best Stocks to Buy Amid Gold Rally,https://insidermonkey.com/blog/--1581404,
InsiderMonkey,Tesla (TSLA) Climbed in Q2 Despite Challenges,https://insidermonkey.com/blog/--1581472,
InsiderMonkey,Getty Images Holdings (GETY) – Shutterstock Merger Inches Closer,https://insidermonkey.com/blog/--1581550,
InsiderMonkey,Immunitybio (IBRX) Targets $80 Million Capital Raise for Business Operations,https://insidermonkey.com/blog/--1581555,
InsiderMonkey,Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects,https://insidermonkey.com/blog/--1581557,
InsiderMonkey,BofA Securities Affirms ‘Buy’ Rating on Taysha Gene Therapies (TSHA) on TSHA-102 Prospects,https://insidermonkey.com/blog/--1581562,
InsiderMonkey,Lifestance Health Group (LFST) Rated as a Buy at BTIG amid Commercially Insured Patients Boost,https://insidermonkey.com/blog/--1581599,
InsiderMonkey,OPKO Health (OPK) to Present Short Bowel Syndrome Treatment in Prague,https://insidermonkey.com/blog/--1581602,
InsiderMonkey,Ardelyx (ARDX) Rated as ‘Overweight’ at Cantor Fitzgerald amid Ibsrela Sales Growth Expectation,https://insidermonkey.com/blog/--1581604,
InsiderMonkey,H.C. Wainwright Affirms MannKind Corp (MNKD)’s ‘Buy’ Rating Buoyed by Product Pipeline,https://insidermonkey.com/blog/--1581607,
InsiderMonkey,"Rosenblatt Initiates Coverage on SentinelOne With a Buy Rating, Sets PT at $24",https://insidermonkey.com/blog/--1581405,
InsiderMonkey,Nuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer Treatment,https://insidermonkey.com/blog/--1581610,
InsiderMonkey,"Cantor Fitzgerald Reiterates Overweight Rating on Tenable Holdings, Maintains PT at $42",https://insidermonkey.com/blog/--1581412,
InsiderMonkey,Canaccord Genuity Maintained a Buy Rating on Rhythm Pharmaceuticals (RYTM),https://insidermonkey.com/blog/--1581485,
InsiderMonkey,Iovance Biotherapeutics (IOVA): Promising TIL Therapy Gains Momentum Amid Funding Challenges,https://insidermonkey.com/blog/--1581616,
InsiderMonkey,Akamai Technologies Partners With Aqua Security to Deliver AI-Powered Integrated Solution,https://insidermonkey.com/blog/--1581423,
